4th Quarter - Amendment

PHARMATHENE, INC for PHARMATHENE, INC

Firm
Client
Income
—
Expenses
$177,760
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Biodefense Advanced Research and Development funding for BARDA/HHS. Economic Stimulus/Recovery funding for HHS, BARDA and NIH to supprt advanced R&D for biodefense vaccines and therapeutics.

LobbyistCovered position, as disclosed
MARK EDWARD COOKE —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.